Evidence map›Paper›PMID 40297648›Full record

ArticleERJ open research2025

Performance of two portable exhaled nitric oxide fraction devices compared to a "gold standard" chemiluminescence device.

Leo Thanikkel, Andreas Vogt, Srdjan J Micic, Nadja Delliehausen, Simon Vogt, Alexander Moeller, Zurich Pediatric Exhalomics Group

Abstract read
In one paragraph

Article in ERJ open research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Leo ThanikkelDepartment of Respiratory Medicine, University Children's Hospital Zurich, University of Zurich and Childhood Research Center, Zurich, Switzerland.
Andreas VogtDepartment of Respiratory Medicine, University Children's Hospital Zurich, University of Zurich and Childhood Research Center, Zurich, Switzerland.
Srdjan J MicicDepartment of Respiratory Medicine, University Children's Hospital Zurich, University of Zurich and Childhood Research Center, Zurich, Switzerland.
Nadja DelliehausenDepartment of Respiratory Medicine, University Children's Hospital Zurich, University of Zurich and Childhood Research Center, Zurich, Switzerland.
Simon VogtDepartment of Respiratory Medicine, University Children's Hospital Zurich, University of Zurich and Childhood Research Center, Zurich, Switzerland.
Alexander MoellerDepartment of Respiratory Medicine, University Children's Hospital Zurich, University of Zurich and Childhood Research Center, Zurich, Switzerland.ORCID https://orcid.org/0000-0001-7284-4251
Zurich Pediatric Exhalomics Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Recent guidelines for the diagnosis of asthma in schoolchildren recommend the measurement of exhaled nitric oxide fraction ( Methods: 106 children aged 6-17 years under investigation or monitoring for asthma underwent Results: All devices showed high repeatability across a wide Conclusions: Both portable devices showed limited interchangeability with the gold standard, making them less applicable for research and disease monitoring purposes. However, good overall agreement at the European Respiratory Society cut-off level (25 ppb) suggests potential as a simple and convenient screening tool in clinical settings for initial asthma diagnosis.

Identifiers

PMID40297648
PMCPMC12036587

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.